Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

NASDAQ:CROX - Nasdaq - US2270461096 - Common Stock - Currency: USD

105.18  -1.45 (-1.36%)

After market: 105 -0.18 (-0.17%)

Fundamental Rating

7

Taking everything into account, CROX scores 7 out of 10 in our fundamental rating. CROX was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX gets an excellent profitability rating and is at the same time showing great financial health properties. CROX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes CROX very considerable for value and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year CROX was profitable.
CROX had a positive operating cash flow in the past year.
CROX had positive earnings in each of the past 5 years.
In the past 5 years CROX always reported a positive cash flow from operatings.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

With an excellent Return On Assets value of 18.90%, CROX belongs to the best of the industry, outperforming 94.00% of the companies in the same industry.
CROX has a better Return On Equity (48.63%) than 96.00% of its industry peers.
CROX has a better Return On Invested Capital (21.12%) than 92.00% of its industry peers.
CROX had an Average Return On Invested Capital over the past 3 years of 22.59%. This is significantly above the industry average of 11.17%.
Industry RankSector Rank
ROA 18.9%
ROE 48.63%
ROIC 21.12%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

CROX's Profit Margin of 23.35% is amongst the best of the industry. CROX outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of CROX has grown nicely.
CROX has a better Operating Margin (24.84%) than 98.00% of its industry peers.
CROX's Operating Margin has improved in the last couple of years.
CROX's Gross Margin of 59.25% is fine compared to the rest of the industry. CROX outperforms 76.00% of its industry peers.
CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.84%
PM (TTM) 23.35%
GM 59.25%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CROX is creating value.
Compared to 1 year ago, CROX has less shares outstanding
Compared to 5 years ago, CROX has less shares outstanding
The debt/assets ratio for CROX has been reduced compared to a year ago.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.75 indicates that CROX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.75, CROX is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
CROX has a debt to FCF ratio of 1.68. This is a very positive value and a sign of high solvency as it would only need 1.68 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 1.68, CROX is doing good in the industry, outperforming 80.00% of the companies in the same industry.
CROX has a Debt/Equity ratio of 0.75. This is a neutral value indicating CROX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.75, CROX is not doing good in the industry: 64.00% of the companies in the same industry are doing better.
Although CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 1.68
Altman-Z 3.75
ROIC/WACC2.27
WACC9.29%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.52 indicates that CROX should not have too much problems paying its short term obligations.
CROX's Current ratio of 1.52 is on the low side compared to the rest of the industry. CROX is outperformed by 72.00% of its industry peers.
A Quick Ratio of 0.97 indicates that CROX may have some problems paying its short term obligations.
CROX has a worse Quick ratio (0.97) than 62.00% of its industry peers.
CROX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 0.97
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.55% over the past year.
The Earnings Per Share has been growing by 51.64% on average over the past years. This is a very strong growth
Looking at the last year, CROX shows a small growth in Revenue. The Revenue has grown by 2.09% in the last year.
CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.23% yearly.
EPS 1Y (TTM)5.55%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-0.66%
Revenue 1Y (TTM)2.09%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-0.14%

3.2 Future

Based on estimates for the next years, CROX will show a small growth in Earnings Per Share. The EPS will grow by 2.84% on average per year.
Based on estimates for the next years, CROX will show a small growth in Revenue. The Revenue will grow by 2.29% on average per year.
EPS Next Y-2.17%
EPS Next 2Y0.79%
EPS Next 3Y-0.62%
EPS Next 5Y2.84%
Revenue Next Year1.61%
Revenue Next 2Y2.23%
Revenue Next 3Y1.59%
Revenue Next 5Y2.29%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

CROX is valuated reasonably with a Price/Earnings ratio of 8.01.
Based on the Price/Earnings ratio, CROX is valued cheaper than 90.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.50, CROX is valued rather cheaply.
The Price/Forward Earnings ratio is 7.87, which indicates a rather cheap valuation of CROX.
CROX's Price/Forward Earnings ratio is rather cheap when compared to the industry. CROX is cheaper than 90.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, CROX is valued rather cheaply.
Industry RankSector Rank
PE 8.01
Fwd PE 7.87
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CROX is valued a bit cheaper than the industry average as 74.00% of the companies are valued more expensively.
CROX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CROX is cheaper than 88.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.67
EV/EBITDA 6.69
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

CROX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y0.79%
EPS Next 3Y-0.62%

0

5. Dividend

5.1 Amount

No dividends for CROX!.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (7/18/2025, 8:00:01 PM)

After market: 105 -0.18 (-0.17%)

105.18

-1.45 (-1.36%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-31 2025-07-31/amc
Inst Owners101.51%
Inst Owner Change0%
Ins Owners2.49%
Ins Owner Change5.65%
Market Cap5.90B
Analysts81.9
Price Target129.76 (23.37%)
Short Float %11.33%
Short Ratio4.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.88%
Min EPS beat(2)9.31%
Max EPS beat(2)18.44%
EPS beat(4)4
Avg EPS beat(4)12.98%
Min EPS beat(4)9.31%
Max EPS beat(4)18.44%
EPS beat(8)8
Avg EPS beat(8)14.09%
EPS beat(12)12
Avg EPS beat(12)14.76%
EPS beat(16)16
Avg EPS beat(16)17.35%
Revenue beat(2)2
Avg Revenue beat(2)1.05%
Min Revenue beat(2)0.88%
Max Revenue beat(2)1.22%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.11%
Max Revenue beat(4)1.22%
Revenue beat(8)4
Avg Revenue beat(8)0.39%
Revenue beat(12)7
Avg Revenue beat(12)0.52%
Revenue beat(16)10
Avg Revenue beat(16)1.27%
PT rev (1m)-0.5%
PT rev (3m)-1.15%
EPS NQ rev (1m)-0.49%
EPS NQ rev (3m)0.25%
EPS NY rev (1m)-1.83%
EPS NY rev (3m)-3.65%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE 8.01
Fwd PE 7.87
P/S 1.44
P/FCF 6.67
P/OCF 6.19
P/B 2.99
P/tB N/A
EV/EBITDA 6.69
EPS(TTM)13.13
EY12.48%
EPS(NY)13.36
Fwd EY12.7%
FCF(TTM)15.76
FCFY14.99%
OCF(TTM)16.99
OCFY16.16%
SpS73.14
BVpS35.13
TBVpS-9.18
PEG (NY)N/A
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 18.9%
ROE 48.63%
ROCE 23.35%
ROIC 21.12%
ROICexc 21.96%
ROICexgc 53.87%
OM 24.84%
PM (TTM) 23.35%
GM 59.25%
FCFM 21.55%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexcg growth 3Y-0.46%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 1.68
Debt/EBITDA 1.36
Cap/Depr 95.51%
Cap/Sales 1.68%
Interest Coverage 11.16
Cash Conversion 87.36%
Profit Quality 92.29%
Current Ratio 1.52
Quick Ratio 0.97
Altman-Z 3.75
F-Score6
WACC9.29%
ROIC/WACC2.27
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.55%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-0.66%
EPS Next Y-2.17%
EPS Next 2Y0.79%
EPS Next 3Y-0.62%
EPS Next 5Y2.84%
Revenue 1Y (TTM)2.09%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-0.14%
Revenue Next Year1.61%
Revenue Next 2Y2.23%
Revenue Next 3Y1.59%
Revenue Next 5Y2.29%
EBIT growth 1Y-4.07%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-0.47%
EBIT Next 3Y-3.04%
EBIT Next 5Y3.43%
FCF growth 1Y53.79%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y39.75%
OCF growth 3Y20.5%
OCF growth 5Y61.62%